Literature DB >> 6201053

Anti-IgE-induced histamine release from rat tissues passively sensitized in vivo with myeloma IgE differs with strain and mast cell source.

H Bergstrand, A Björnsson, I M Frick, B Lundquist, R Pauwels, H Bazin.   

Abstract

Four different strains of rats, BDII, E3, LE, and OM/N, each with a low basal serum level of IgE, were examined with respect to anti-IgE- and ConA-induced release of histamine from serosal mast cells and chopped lung tissue. Tests were performed before and three days after i.p. injection of a graded dose of myeloma IgE (IR 162)-containing ascitic fluid. There was a clearcut strain difference in response capacity with respect to ConA- and anti-IgE-induced release of histamine from serosal mast cells before myeloma IgE-injection. Response capacity increased in some but not all strains after myeloma IgE injection; increase in response capacity of serosal mast cells did not correlate to that of chopped lung tissue. Analogous findings were observed when two of the strains, LE and E3, were passively sensitized by i.p. injection with serum containing another myeloma IgE (IR2). These results indicate that differences exist between mast cells of different rat strains, and within strain between mast cells of various tissues in capacity to become sensitized to myeloma IgE.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201053     DOI: 10.1007/bf01966636

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  34 in total

1.  Correlation between in vitro anaphylactic histamine release from tissues and reagin titer in rat.

Authors:  S Yamamoto; K Seo; Y Fujiwara; M Maeda; T Yamura
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

2.  Homocytotropic antibody response in the rat infected with the nematode, Nippostrongylus brasiliensis. II. Characteristics of the immune response.

Authors:  R J Wilson; K J Bloch
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

3.  The non-specific enhancement of allergy. II. Precipitation of anaphylactic in vitro response capacity and serum IgE and IgG2a antibody synthesis in primed but non-responding rats by injection of alum.

Authors:  H Bergstrand; I Andersson; I Nyström; R Pauwels; H Bazin
Journal:  Allergy       Date:  1983-05       Impact factor: 13.146

4.  A comparative study of histamine secretion from rat peritoneal and pleural mast cells.

Authors:  K E Barrett; F L Pearce
Journal:  Agents Actions       Date:  1982-04

5.  Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release.

Authors:  M C Conroy; N F Adkinson; L M lichtenstein
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

6.  The respiratory response in sensitized rats to aerosol challenge.

Authors:  F Carswell; J Oliver
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

7.  Lymphocytes bearing Fc receptors for IgE. II. Induction of Fcepsilon-receptor bearing rat lymphocytes by IgE.

Authors:  J Yodoi; T Ishizaka; K Ishizaka
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

8.  Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow.

Authors:  E Razin; J M Mencia-Huerta; R A Lewis; E J Corey; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Binding properties of IgE receptors on normal mouse mast cells.

Authors:  A R Sterk; T Ishizaka
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

10.  The respiratory response of sensitized rats to challenge with antigen aerosols.

Authors:  H Piechuta; M E Smith; N N Share; G Holme
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

View more
  1 in total

1.  Immunologically induced pleural and peritoneal mast cell histamine release: difference in responsiveness in relation to secretagogue and rat strain used.

Authors:  H Bergstrand; I Andersson; A Björnsson; I M Frick; B Lundquist; R Pauwels
Journal:  Agents Actions       Date:  1984-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.